Russell Investments Group, Ltd. Adicet Bio, Inc. Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$1.21 - $2.4 $8,317 - $16,497	6,874 Added 1380.32%	7,372 $8,000
Q1 2024 May 08, 2024	BUY	$1.76 - $3.45 $876 - $1,718	498 New	498 $1,000
Q3 2023 Nov 13, 2023	SELL	$1.37 - $3.4 $87,281 - $216,610	-63,709 Reduced 98.91%	701 $0
Q2 2023 Aug 10, 2023	SELL	$2.13 - $7.13 $234,939 - $786,439	-110,300 Reduced 63.13%	64,410 $156,000
Q1 2023 May 09, 2023	BUY	$5.52 - $9.23 $358,634 - $599,673	64,970 Added 59.2%	174,710 $1.01 Million
Q4 2022 Feb 08, 2023	BUY	$7.72 - $21.27 $113,105 - $311,626	14,651 Added 15.41%	109,740 $981,000
Q3 2022 Nov 04, 2022	BUY	$13.43 - $18.74 $592,021 - $826,096	44,082 Added 86.42%	95,089 $1.35 Million
Q2 2022 Jul 29, 2022	BUY	$10.26 - $20.81 $523,331 - $1.06 Million	51,007 New	51,007 $743,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.